Healthcare Webinars

This 60-min webinar will provide an overview of the demographic shifts and the stressors that preceded the pandemic and the challenges that hospitals faced during this surge.

Presented by Douglas Austin Initially discovered in a Japanese man's ear in 2009, Candia auris has spread globally since then and has become a pathogen of concern. If invasive, this highly drug-resistant super fungus has a mortality rate of up to 34% and can quickly colonize patients throughout a facility. What can we do to tackle this emerging issue? This webinar discusses what Candida auris is, what we know about its transmission and the effect it has on hospitals and long-term care facilities.

The presentation is an introduction to the Feeling Safe Programme, which is a new cognitive-behavioral treatment for patients with psychosis. Developed with over a decade of research, it is the most effective psychological treatment for persecutory delusions. Half of the patients have recovered from their persecutory delusions with the Feeling Safe Programme.

Over the past two decades, the biopharmaceutical market has expanded, with monoclonal antibodies exhibiting a 26 percent higher approval rate than other drugs. Join this webinar to investigate the effects of simultaneously adjusting temperature and osmolality on the generation of host cell proteins (HCPs), antibody yield, and cell growth.

Discover a groundbreaking webinar delving into the statistical data strategies and considerations of ophthalmology clinical trials, as well as supporting Data Monitoring Committees (DMC) charged with safety and efficacy reviews. Join this webinar to gain insights into ophthalmology clinical trials’ statistical data strategies and learn on best practices for establishing and reporting ophthalmic data.

Join us on Thursday 8 February for a webinar delivered by Tony Lloyd, CEO of The ADHD Foundation Neurodiversity Charity, exploring children's mental health, 'Understanding myself, liking myself, being me. Helping your child to understand strategies & lifestyles for good mental health Supporting Parents & Carers

Register to learn about the personal journey of living with amyotrophic lateral sclerosis (ALS) A Journey With RADICAVA ORS® (edaravone) Wednesday, February 7, 2024 at 4:00 PM EST. This online session reveals the unique perspective of Stacy, someone living with ALS who hopes to support others on their journey by sharing her knowledge and experience. Together, Jodi and Stacy will discuss initial symptoms that led to diagnosis and Stacy's transition to treatment with RADICAVA ORS®. Stacy also talks about the importance of being your own best advocate along the way. Register for this online session to view this program and to receive updates with helpful information and the latest resources about RADICAVA ORS®.

The TETRIS study collected a year of observational data of resuscitative thoracotomy performed for traumatic injury in the prehospital or ED setting in the UK. The objective was to evaluate current practice including incidence, indications, interventions, injury patterns, demographics, and outcomes.This webinar will feature the results of the study followed by an expert panel discussion on current evidence and the implications of this study for future practice.Speakers: Caroline Leech, Lisa Ramage, Harriet Tucker, Zane Perkins, Richard Steyn

This webinar is presented by the Alabama Regional Center for Infection Prevention and Control Training and Technical Assistance. Kate Draper, Council of State and Territorial Epidemiologists Applied Epidemiology Fellow with the Infectious Diseases & Outbreaks Division at the Alabama Department of Public Health (ADPH), will present “Understanding Multidrug-Resistant Organisms”. Kate will provide an overview of MDROs, their impact, causes, and potential solutions. This webinar was co-sponsored by the Alabama Regional Center for Infection Prevention and Control and the Region IV Public Health Training Center.

Introducing a new bioanalytical technology for assessing monoclonal antibody (mAb) sample quality from early-stage candidate selection to manufacturability evaluation - mass photometry. In this webinar, you’ll discover how mass photometry can be used for forced antibody degradation assessment, a crucial aspect of research and development for recombinant mAb therapeutics. Our expert speaker will also demonstrate how mass photometry data compares to and complements the current gold standard, size exclusion chromatography (SEC), as well as providing insights into other applications of mass photometry in therapeutic antibody R&D labs. Attend this webinar to discover: - How mass photometry enables rapid assessment of sample quality - How mass photometry complements other analytical methods for antibody sample characterization, such as SEC - What the sample requirements are for detection of antibody aggregates and fragments